FdaApplication

ANDA 203481

Back to search

Identifiers

Properties

PropertyValue
applicant_nameBRECKENRIDGE PHARMACEUTICAL INC
application_typeANDA
approval_date2017-07-03

Products (3)

ProductActive ingredientStrengthDosage form
OMEPRAZOLEOMEPRAZOLE20MGCAPSULE, DELAYED REL PELLETS;ORAL
OMEPRAZOLEOMEPRAZOLE40MGCAPSULE, DELAYED REL PELLETS;ORAL
OMEPRAZOLEOMEPRAZOLE10MGCAPSULE, DELAYED REL PELLETS;ORAL

3 products